CRISPR Therapeutics
CRSP
$55.65
Share price
-1.35%
Change (1 day)
8.95%
Change (1 year)
CRISPR Therapeutics (CRSP) Fails to deliver data
Key failure to deliver metrics for CRISPR Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $9.76 M
- Last 3 months FTD volume: $61.85 M
- Last year FTD volume: $0.20 B
Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016
Volume in USD (price x number of shares), data since 2016CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $61.37 M | -58.64% |
| 2023 | $0.14 B | 1.4% |
| 2022 | $0.14 B | 8.89% |
| 2021 | $0.13 B | 22.76% |
| 2020 | $0.10 B | -2.51% |
| 2019 | $0.11 B | 59.97% |
| 2018 | $70.19 M | 265.26% |
| 2017 | $19.21 M | 319.28% |
| 2016 | $4.58 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.19 M | $6.79 M | 🇺🇸 USA |